Citation: Pb. Gilbert, Interpretability and robustness of sieve analysis models for assessing HIVstrain variations in vaccine efficacy, STAT MED, 20(2), 2001, pp. 263-279
Authors:
Havlir, DV
Gilbert, PB
Bennett, K
Collier, AC
Hirsch, MS
Tebas, P
Adams, EM
Wheat, LJ
Goodwin, D
Schnittman, S
Holohan, MK
Richman, DD
Citation: Dv. Havlir et al., Effects of treatment intensification with hydroxyurea in HIV-infected patients with virologic suppression, AIDS, 15(11), 2001, pp. 1379-1388
Citation: Iw. Mckeague et al., Omnibus tests for comparison of competing risks with adjustment for covariate effects, BIOMETRICS, 57(3), 2001, pp. 818-828
Authors:
Gilbert, PB
Hanna, GJ
De Gruttola, V
Martinez-Picado, J
Kuritzkes, DR
Johnson, VA
Richman, DD
D'Aquila, RT
Citation: Pb. Gilbert et al., Comparative analysis of HIV type 1 genotypic resistance across antiretroviral trial treatment regimens, AIDS RES H, 16(14), 2000, pp. 1325-1336
Citation: Pb. Gilbert, Comparison of competing risks failure time methods and time-independent methods for assessing strain variations in vaccine protection, STAT MED, 19(22), 2000, pp. 3065-3086
Authors:
Gilbert, PB
Ribaudo, HJ
Greenberg, L
Yu, G
Bosch, RJ
Tierney, C
Kuritzkes, DR
Citation: Pb. Gilbert et al., Considerations in choosing a primary endpoint that measures durability of virological suppression in an antiretroviral trial, AIDS, 14(13), 2000, pp. 1961-1972
Citation: Pb. Gilbert, Large sample theory of maximum likelihood estimates in semiparametric biased sampling models, ANN STATIST, 28(1), 2000, pp. 151-194
Citation: Pb. Gilbert et al., Maximum likelihood estimation in semiparametric selection bias models withapplication to AIDS vaccine trials, BIOMETRIKA, 86(1), 1999, pp. 27-43
Citation: Pb. Gilbert et al., Statistical methods for assessing differential vaccine protection against human immunodeficiency virus types, BIOMETRICS, 54(3), 1998, pp. 799-814